One prominent dog study used CRISPR-Cas9 (delivered by adeno-associated viruses AAV) to restore the expression of dystrophin in a dog model of Duchenne muscular dystrophy, accompanied by improved muscle histology and amelioration of the disease [274]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.